Labiotech.eu

News and Trends 15 Mar 2022

Biotech Stocks in “Total Eclipse” as Financial Pressures Mount

More than a year after biotech stock indices peaked, the markets are worse than ever. Meanwhile, rumors of an impending wave of opportunistic biotech acquisitions are yet to materialize. In February of last year, biotech stocks across Europe and the US saw the end of a pandemic-fuelled growth spurt. Since then, the stock growth of […]

March 15, 2022 - 6 minutesmins - By Jonathan Smith

Antoine Papiernik Sofinnova Partners life science

Opinion 14 Mar 2022

The Secrets to 50 Years of Success in Life Sciences Investment

The European life sciences venture capital firm Sofinnova Partners is celebrating its 50th birthday this year. Sofinnova’s Chairman and Managing Partner, Antoine Papiernik, outlines key lessons the company has learned in its long history in the biotech industry. Meet a couple who have been married for 50 years and most of us, I imagine, would […]

March 14, 2022 - 7 minutesmins - By Antoine Papiernik

News and Trends 11 Mar 2022

Microbiome Space in Spotlight as Microbiotica Sets Funding Record

Competition is heating up in the microbiome niche as UK-based Microbiotica raised €60M (£50M) in a Series B round to advance two candidates designed to treat cancer and ulcerative colitis. Microbiotica’s financing sets a record in Europe for microbiome specialist biotechs. The round was co-led by Sweden’s Flerie Invest and China-based Tencent, and was supported […]

March 11, 2022 - 3 minutesmins - By Victor Kotsev

Scenic biotech lysosomal storage disorders

News and Trends 10 Mar 2022

Emerging Startups Take Aim at Lysosomal Storage Disorders

Lysosomal storage disorders such as Niemann-Pick type C have proved difficult to tackle in the biotech industry. With recent funding rounds in the bag, Scenic Biotech and Maze Therapeutics strive to treat these conditions by activating protective genes. Lysosomal storage disorders are inherited conditions caused by mutations in metabolic enzymes found inside our cells, leading […]

March 10, 2022 - 4 minutesmins - By Jonathan Smith

News and Trends 8 Mar 2022

The Top European Biotech Investments in February 2022

Companies developing lab automation, ophthalmological treatments, and novel foods received Europe’s top biotech investments in February 2022. European and Israeli biotech investments in February 2022 narrowly beat January’s performance. Life sciences companies in these regions bagged 52 private investments and initial public offerings (IPOs), worth €664M in total. Meanwhile, January’s tally was 41 deals totaling […]

March 8, 2022 - 4 minutesmins - By Jonathan Smith

In Depth 7 Mar 2022

Multiplexing Speeds up Writing and Editing DNA

While scientists can read DNA fast, editing and writing it is not that easy. Increasing the speed of editing and writing DNA sequences will be critical to ushering in new applications of genome engineering. Much of biotech is about reverse-engineering the designs that billions of years of evolution have put together. To be able to […]

March 7, 2022 - 6 minutesmins - By Sachin Rawat

News and Trends 3 Mar 2022

Europe’s Ophthalmology Scene Stays Hot for Biotech Funding

Ophthalmology-focused startups had a record year for venture capital funding in 2021. Impressive Series A rounds and collaborations hint at a continuing upward trend for the field in 2022. Biotech companies researching treatments for ophthalmological conditions experienced a splurge of venture capital (VC) funding in 2021, with the total more than trebling the haul from […]

March 3, 2022 - 5 minutesmins - By Jonathan Smith

News and Trends 1 Mar 2022

European Biotech Industry Braces as War Erupts in Ukraine

Europe has been blindsided by its biggest war in decades with Russia’s invasion of Ukraine. Amid a raging humanitarian crisis, the biotech industry is preparing for increasing economic uncertainty, cyber threats, and clinical trial disruptions. The invasion of Ukraine by Russian forces last week caused a widespread outcry from the European community. The geopolitical landscape […]

March 1, 2022 - 7 minutesmins - By Jonathan Smith

In Depth 28 Feb 2022

Biorobotics Teaches Machines to Sense and Respond to the World

Integrating biology and robotics would allow robots to feel, smell, or hear in order to react to changing environments, opening a wide range of applications. Our senses allow us to interact with our surroundings. They are also the basis for learning. In the quest to make machines more efficient, researchers are looking at one of […]

February 28, 2022 - 7 minutesmins - By Carlos de Rojas

Industrial plant sustainability bioeconomy

News and Trends 23 Feb 2022

EU Bioeconomy Fund Bags €300M to Scale up Sustainability Companies

The European Circular Bioeconomy Fund has smashed its funding target by raising €300M. The aim is to help sustainability-focused biotechs scale up and usher in a ‘bio-revolution’ in Europe. As European economies grapple with the aftershocks of the Covid-19 pandemic, policymakers have pledged to prioritize sustainability in plans such as the European Green Deal. However, […]

February 23, 2022 - 4 minutesmins - By Jonathan Smith

News and Trends 22 Feb 2022

Fast Stroke Treatments in the Works with TargED’s €39M Series A

Patients with sudden strokes and blood clotting conditions need faster and safer treatments. The Dutch company TargED Biopharmaceuticals has raised a €39M Series A round to fund the development of a fast-acting protein drug that could bridge this gap. Time is of the essence when treating acute ischemic stroke, a condition caused by a blood […]

February 22, 2022 - 5 minutesmins - By Jonathan Smith

Belgium biotech vc fund newton biocapital japan

News and Trends 18 Feb 2022

Belgian VC Fund Leads Investment Wave in Japanese Biotech

As US and European investor interest in Japanese biopharma startups spikes, the Belgian venture capital firm Newton Biocapital has launched a €150M fund to harness synergy between European and Japanese life sciences. Japan boasts a world-class technology industry in addition to a thriving life sciences scene. The nation hosts large companies including Takeda, Eisai, and […]

February 18, 2022 - 4 minutesmins - By Jonathan Smith

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Biotech Stocks in “Total Eclipse” as Financial Pressures Mount

The Secrets to 50 Years of Success in Life Sciences Investment

Microbiome Space in Spotlight as Microbiotica Sets Funding Record

Emerging Startups Take Aim at Lysosomal Storage Disorders

The Top European Biotech Investments in February 2022

Multiplexing Speeds up Writing and Editing DNA

Europe’s Ophthalmology Scene Stays Hot for Biotech Funding

European Biotech Industry Braces as War Erupts in Ukraine

Biorobotics Teaches Machines to Sense and Respond to the World

EU Bioeconomy Fund Bags €300M to Scale up Sustainability Companies

Fast Stroke Treatments in the Works with TargED’s €39M Series A

Belgian VC Fund Leads Investment Wave in Japanese Biotech

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!